BiomX Inc.
BiomX Inc. (PHGE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
phge · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$38.00
Consensus
$38.00
+4917.8% upside
Low
$38.00
Median: $38 · Last Close: $0.76
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.76 | ↑ 0.00% |
1-day model range: $0.72–$0.8. Peak: $0.8 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PHGE · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-09 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-11-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-08 | HC Wainwright& Co. | Maintains | Buy→Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on BiomX Inc. (PHGE) stock. Of the recent 26 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover PHGE.
Analyst Recommendation Trends
PHGE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$24M
EPS This Year
$-20.35
EPS Next Year
$-5.85
↓ 71.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast PHGE EPS of $-20.35 for the current fiscal year, based on estimates from 1 analysts. The PHGE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PHGE stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PHGE price target is $38.00 (+4917.8% upside), with an analyst consensus of Buy.
The PHGE short-term stock prediction for tomorrow is $0.76 (+0.00%).
BiomX Inc. trades on AMEX under the ticker PHGE. The PHGE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
PHGE forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month PHGE price target is $38.00, with a high forecast of $38.00 and a low of $38.00. The median price target is shown in the chart above when available. This implies +4917.8% potential upside from the current price of $0.76.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.